Published in Cancer on June 20, 2011
Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008. Breast Cancer Res Treat (2012) 0.96
Stage, treatment and outcomes for patients with breast cancer in British Columbia in 2002: a population-based cohort study. CMAJ Open (2013) 0.75
Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg (2004) 3.65
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg (2007) 2.28
Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg (2002) 2.03
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res (2009) 1.88
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol (2005) 1.84
Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol (2008) 1.66
Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg (2003) 1.58
Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg (2002) 1.54
Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2008) 1.51
An interaction of race and ethnicity with socioeconomic status in rectal cancer outcomes. Ann Surg (2011) 1.49
Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg (2013) 1.47
Endoscopy education in general surgery residencies: meeting the new RRC requirements. J Surg Res (2010) 1.42
Experience and attitudes of surgeons toward palliation in cancer. Arch Surg (2005) 1.37
Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer (2008) 1.36
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg (2006) 1.31
Treatment options for metaplastic breast cancer. ISRN Oncol (2012) 1.30
Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2011) 1.26
Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Ann Intern Med (2013) 1.26
Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol (2009) 1.25
Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg (2004) 1.24
Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed. Arch Surg (2004) 1.23
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother Pharmacol (2004) 1.20
Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol (2005) 1.19
Surgical resident involvement is safe for common elective general surgery procedures. J Am Coll Surg (2011) 1.17
ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer. Autophagy (2009) 1.14
Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res (2009) 1.14
Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate (2010) 1.13
Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg (2009) 1.10
Lack of Insurance is Associated With Increased Risk for Hernia Complications. Ann Surg (2009) 1.09
Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther (2002) 1.08
Adjuvant radiation therapy is associated with improved survival for adenoid cystic carcinoma of the breast. J Surg Oncol (2010) 1.08
Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer (2008) 1.06
An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg (2010) 1.05
Hospital readmissions: necessary evil or preventable target for quality improvement. Ann Surg (2014) 1.05
Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys (2007) 1.05
Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol (2003) 1.04
Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States. J Thorac Oncol (2013) 1.03
Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream. Melanoma Res (2011) 1.03
The role of Akt activation in the response to chemotherapy in pancreatic cancer. Anticancer Res (2010) 1.02
Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg (2008) 1.00
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg (2011) 0.99
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol (2009) 0.99
Medullary carcinoma of the breast: a population-based perspective. Med Oncol (2011) 0.98
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer. Lung Cancer (2005) 0.98
The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery (2003) 0.98
Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Arch Surg (2009) 0.97
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys (2006) 0.97
The impact of age on quality measure adherence in colon cancer. J Am Coll Surg (2011) 0.96
Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol (2007) 0.95
Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer. J Surg Res (2003) 0.92
Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res (2009) 0.92
P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy. Hum Pathol (2012) 0.91
Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Ann Thorac Surg (2010) 0.91
Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma. J Surg Res (2010) 0.90
Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy. Semin Oncol (2004) 0.90
Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys (2011) 0.90
Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine (Phila Pa 1976) (2002) 0.90
BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J Cell Biochem (2007) 0.89
A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol (2007) 0.89
Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis. Cancer (2009) 0.89
Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg (2006) 0.89
Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer. Int J Radiat Oncol Biol Phys (2012) 0.89
Treatment disparities in Hispanic rectal cancer patients: a SEER database study. Am Surg (2006) 0.88
Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res (2011) 0.88
ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J Surg Res (2008) 0.87
Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) (2013) 0.87
Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors. Arch Dermatol (2011) 0.86
Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg (2010) 0.86
Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era. Med Oncol (2010) 0.86
Surgery in the aged population: surgical oncology. Arch Surg (2003) 0.86
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res (2012) 0.86
Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation. Head Neck (2014) 0.86
Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer. Head Neck (2013) 0.86
Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol (2011) 0.85
Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res (2011) 0.85
Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys (2012) 0.85
Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma. J Surg Oncol (2014) 0.85
Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis. J Surg Oncol (2010) 0.85